Wolverine Asset Management’s Kindred Biosciences, Inc. KIN Stock Holding History

Wolverine Asset Management’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-7,800	Closed	-$71K	–	2712
2021 Q2	$71K	Buy	+7,800	New	+$45.4K	﹤0.01%	1568

Other funds holding KIN

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Wolverine Asset Management's KIN Position: Q3 2021 in Review

Wolverine Asset Management sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 7,800 shares — an estimated $71K sold.

Wolverine Asset Management first reported a position in KIN in Q2 2021 and held it in 1 quarter. The position peaked at $71K in Q2 2021. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

Wolverine Asset Management reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
Wolverine Asset Management sold 7,800 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $71K.
Wolverine Asset Management first reported a position in Kindred Biosciences, Inc. in Q2 2021 and held it in 1 quarter.
Wolverine Asset Management's Kindred Biosciences, Inc. position peaked at $71K in Q2 2021.
1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on Wolverine Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.